US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

CNS/Neurology Market Research Reports & Industry Analysis

RSS Feeds

CNS/Neurology Industry Research & Market Reports

1  2    4    6  7  8  9  10  
Brain Cancer Treatment Drugs Markets in China
6/1/2014 | published by: Asia Market Information & Development Company
... continue to grow. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2003, 2008 and 2013) and long-term ...  |  read more...
USD 4,000
Are neurologists ready to embrace gene therapy? - Physician Views
6/11/2014 | published by: FirstWord
... Between the beginning of last year and early April 2014, however, 11 different companies specialising in gene therapy raised $618 million from venture capitalists and the public markets. Momentum for this approach has been driven ...  |  read more...
USD 645
Autism Global Clinical Trials Review, H1, 2014
5/30/2014 | published by: GlobalData
... relating to the clinical trials on Autism. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage ...  |  read more...
USD 2,500
PharmaPoint: Major Depressive Disorder - Current and Future Players
5/30/2014 | published by: GlobalData
... with in-depth analysis on the companies in the rapidly growing Major Depressive Disorder Market. The report identifies and analyses the key companies shaping and driving the global Major Depressive Disorder market. The report provides insight ...  |  read more...
USD 2,995
Tourette Syndrome Global Clinical Trials Review, H2, 2014
7/31/2014 | published by: GlobalData
... information and data relating to the clinical trials on Tourette Syndrome. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook ...  |  read more...
USD 2,500
ADHD Therapeutics to 2020 - Broadened Diagnostic Criteria and Growing Adult Prevalence to Drive Market Growth despite Patent Expirations
7/31/2014 | published by: GBI Research
... Criteria and Growing Adult Prevalence to Drive Market Growth despite Patent Expirations” Changes in diagnostic criteria have reduced the symptom threshold for diagnosis and finally bring the acceptance of adult ADHD to the clinical setting, ...  |  read more...
USD 4,995
Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM
8/20/2014 | published by: GBI Research
... research, Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM, which provides in-depth analysis of the Glioblastoma Multiforme (GBM) therapeutics market within ...  |  read more...
USD 4,995
Global Anti-Migraine Drugs Market: Trends and Opportunities (2014-19)
6/1/2014 | published by: Daedal Research
... World’s Top 20 disabling medical illnesses. It is anticipated that launches of many generic migraine drugs over the next several years will steadily increase diagnosis and drug-treatment rates, leading to sustained annual global growth of ...  |  read more...
USD 700
PharmaPoint: Major Depressive Disorder - 5EU Drug Forecast and Market Analysis to 2023
5/30/2014 | published by: GlobalData
... competitive market, with more than 30 marketed products available for the treatment of patients with MDD. The depression market is about to enter a dynamic phase with imminent patent expiries for top selling products, such ...  |  read more...
USD 6,995
Lexapro (Major Depressive Disorder) - Forecast and Market Analysis to 2023
5/30/2014 | published by: GlobalData
... with more than 30 marketed products available for the treatment of patients with MDD. The depression market is about to enter a dynamic phase with imminent patent expiries for top selling products, such as Eli ...  |  read more...
USD 3,495
Cognitive Impairment Associated With Schizophrenia (CIAS) Global Clinical Trials Review, H1, 2014
6/20/2014 | published by: GlobalData
... Impairment Associated With Schizophrenia (CIAS) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Cognitive Impairment Associated With Schizophrenia (CIAS). It includes an overview of the trial numbers ...  |  read more...
USD 2,500
Viibryd (Major Depressive Disorder) - Forecast and Market Analysis to 2023
5/30/2014 | published by: GlobalData
... with more than 30 marketed products available for the treatment of patients with MDD. The depression market is about to enter a dynamic phase with imminent patent expiries for top selling products, such as Eli ...  |  read more...
USD 3,495
Fetzima (Major Depressive Disorder) - Forecast and Market Analysis to 2023
5/30/2014 | published by: GlobalData
... with more than 30 marketed products available for the treatment of patients with MDD. The depression market is about to enter a dynamic phase with imminent patent expiries for top selling products, such as Eli ...  |  read more...
USD 3,495
Savella (Major Depressive Disorder) - Forecast and Market Analysis to 2023
5/30/2014 | published by: GlobalData
... with more than 30 marketed products available for the treatment of patients with MDD. The depression market is about to enter a dynamic phase with imminent patent expiries for top selling products, such as Eli ...  |  read more...
USD 3,495
Abilify (Major Depressive Disorder) - Forecast and Market Analysis to 2023
5/30/2014 | published by: GlobalData
... with more than 30 marketed products available for the treatment of patients with MDD. The depression market is about to enter a dynamic phase with imminent patent expiries for top selling products, such as Eli ...  |  read more...
USD 3,495
Cariprazine (Major Depressive Disorder) - Forecast and Market Analysis to 2023
5/30/2014 | published by: GlobalData
... with more than 30 marketed products available for the treatment of patients with MDD. The depression market is about to enter a dynamic phase with imminent patent expiries for top selling products, such as Eli ...  |  read more...
USD 3,495
ALKS-5461 (Major Depressive Disorder) - Forecast and Market Analysis to 2023
5/30/2014 | published by: GlobalData
... with more than 30 marketed products available for the treatment of patients with MDD. The depression market is about to enter a dynamic phase with imminent patent expiries for top selling products, such as Eli ...  |  read more...
USD 3,495
GLYX-13 (Major Depressive Disorder) - Forecast and Market Analysis to 2023
5/30/2014 | published by: GlobalData
... with more than 30 marketed products available for the treatment of patients with MDD. The depression market is about to enter a dynamic phase with imminent patent expiries for top selling products, such as Eli ...  |  read more...
USD 3,495
Tedatioxetine (Major Depressive Disorder) - Forecast and Market Analysis to 2023
5/30/2014 | published by: GlobalData
... with more than 30 marketed products available for the treatment of patients with MDD. The depression market is about to enter a dynamic phase with imminent patent expiries for top selling products, such as Eli ...  |  read more...
USD 3,495
High-Grade Glioma - Pipeline Review, H1 2014
6/15/2014 | published by: Global Markets Direct
... therapeutic development for High-Grade Glioma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
PharmaPoint: Major Depressive Disorder - Global Drug Forecast and Market Analysis to 2023
5/31/2014 | published by: GlobalData
... competitive market, with more than 30 marketed products available for the treatment of patients with MDD. The depression market is about to enter a dynamic phase with imminent patent expiries for top selling products, such ...  |  read more...
USD 10,995
Global Nerve Navigation System Industry - 2014 Market Research Report
7/28/2014 | published by: 9Dimen Research
... Nerve Navigation System industry, the main region including North American, Europe and Asia etc, and the main country including United States, Germany, Japan and China etc. The report firstly introduced Nerve Navigation System basic information ...  |  read more...
USD 2,850
Global Intracranial Pressure Monitor Industry - 2014 Market Research Report
7/28/2014 | published by: 9Dimen Research
... Intracranial Pressure Monitor industry, the main region including North American, Europe and Asia etc, and the main country including United States, Germany, Japan and China etc. The report firstly introduced Intracranial Pressure Monitor basic information ...  |  read more...
USD 2,850
Global Brain Mapping Instrument Industry - 2014 Market Research Report
7/28/2014 | published by: 9Dimen Research
... Brain Mapping Instrument industry, the main region including North American, Europe and Asia etc, and the main country including United States, Germany, Japan and China etc. The report firstly introduced Brain Mapping Instrument basic information ...  |  read more...
USD 2,850
Neurology: State Industry Market Evaluator
6/30/2014 | published by: BizMiner
... volume, average firm, site and small business sales, sales per employee, market volume by employment class, employment by employment class and more. Additional statistics include failure rates (firms, establishments, small business, startups). startup activity rates ...  |  read more...
USD 699
1  2    4    6  7  8  9  10